Azitra (AZTR) Equity Average (2022 - 2026)
Azitra (AZTR) reported Equity Average of $7.1 million for Q1 2026, up 41.3% on a YoY basis from $5.1 million in Q1 2025, and up 134.88% quarter-over-quarter from $3.0 million in Q4 2025.
Azitra (AZTR) Equity Average (2022 - 2026) Analysis & Trends
Azitra has reported Equity Average for 5 years, with the latest figure at $7.1 million in Q1 2026.
- For the quarter ending Q1 2026, Equity Average rose 41.3% year-over-year to $7.1 million; the trailing twelve-month figure through Mar 2026 stood at $7.1 million (up 41.3% YoY), and the FY2025 full-year result was $4.7 million, up 10.31% from the prior year.
- Equity Average for Q1 2026 stood at $7.1 million, up from $3.0 million in the prior quarter.
- The five-year high for Equity Average was $7.1 million in Q1 2026, with the low at -$37.5 million in Q1 2023.
- Historically, Equity Average has averaged -$4.6 million across 5 years, with a median of $3.3 million in 2025.
- Annual changes were most pronounced in 2023 — Equity Average surged 120.23% — and 2025, when it plunged 55.8%.
- Azitra's Equity Average stood at -$34.3 million in 2022, then soared by 112.04% to $4.1 million in 2023, then jumped by 66.84% to $6.9 million in 2024, then sank by 55.8% to $3.0 million in 2025, then soared by 134.88% to $7.1 million in 2026.
- The last three Equity Average figures came in at $7.1 million (Q1 2026), $3.0 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | 7.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.14 Mn |
| Dec 31, 2025 | 3.04 Mn |
| Sep 30, 2025 | 2.24 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Mar 31, 2025 | 5.05 Mn |
| Dec 31, 2024 | 6.88 Mn |
| Sep 30, 2024 | 4.89 Mn |
| Jun 30, 2024 | 3.03 Mn |
| Mar 31, 2024 | 3.62 Mn |
| Dec 31, 2023 | 4.12 Mn |
| Sep 30, 2023 | 6.28 Mn |
| Jun 30, 2023 | -15.72 Mn |
| Mar 31, 2023 | -37.47 Mn |
| Dec 31, 2022 | -34.25 Mn |
| Sep 30, 2022 | -31.06 Mn |